Abstract
The leading cause of blindness in the developed world results from several disorders that have pathologic ocular neovascularization as the common pathway leading to vision loss. These disorders include exudative age related macular degeneration (AMD), diabetic retinopathy (DR), retinopathy of prematurity (ROP), retinal vein occlusions (RVO) and ocular tumors. Because neovascularization is the common pathway to blindness in these highly prevalent conditions, the recent understanding of the cascade of angiogenesis has led to clinically available molecular therapeutics that have been proven to restore and preserve vision in patients that suffer from these blinding conditions. This article will summarize the emergence of vascular endothelial growth factor (VEGF) as a validated treatment target for and current understanding of the pathophysiology of ocular neovascularization. The article will then cover promising future strategies and therapeutic targets that are aimed at enhancing the efficacy and/or duration of effect of these clinically available anti-VEGF strategies. In particular molecules that target, VEGF, PDGF, Complement, Inflammation and Integrins that are entering or are currently in clinical trials will be reviewed.
Keywords: Vascular Endothelial Growth Factor (VEGF), Age Related Macular Degeneration (AMD), Complement, Diabetic Retinopathy (DR), Ranibizumab, Pegaptanib, Bevacizumab, Bevasiranib, Integrins
Call for Papers in Thematic Issues
From Molecular Mechanisms to Therapeutic Frontiers: The Versatile Roles of Chaperones in Medicine
Chaperones play critical roles in maintaining proteostasis by preventing protein misfolding and aggregation, which constitute central processes to the pathogenesis of numerous diseases such as neurodegeneration, cancer, and inflammatory disorders. This thematic issue will delve into the molecular mechanisms of chaperone function, their involvement in disease progression, and their potential ...read more
Metabolic Reprogramming and Molecular Pharmacology: Innovations in Drug Discovery and Therapeutic Targeting
Metabolic reprogramming is a hallmark of numerous diseases, including cancer, metabolic disorders, and neurodegeneration. Understanding the intricate cell signaling pathways, transduction pathways, and omics-based data is important for the development of novel pharmacological interventions. This special issue of Current Molecular Medicine will be devoted to the current advances in drug ...read more
Molecular and Cellular Mechanisms in Vertigo / Vestibular Disorders
Vertigo and vestibular diseases are common among middle-aged and older adults, significantly increasing the risk of falls and leading to injuries and disabilities. Despite their prevalence, therapeutic advancements are hindered by a limited understanding of the underlying molecular and cellular mechanisms. This Special Issue is dedicated to bridging this gap ...read more
Related Books
Microbial Insights into Wastewater Treatment and Environmental Sustainability
Biological Control for Plant Protection: Recent Advances in Research and Sustainability
From Genes to Algorithms: Navigating the Biotechnology Data Revolution
Phytochemical Arsenal: Understanding Plant Defense Mechanisms Against Nematodes
Controlled Environment Horticulture: Where Plant Biotechnology Meets Sustainable Future
Genetic Diversity of Coronaviruses: From SARSCoV to SARS-CoV-2 – (Part 2)
Wild Vegetables: Morphology, Phytochemistry and Utility - (Part 2)
A Practical Approach to Molecular Cloning
Organoid Technology: Disease Modelling, Drug Discovery, and Personalized Medicine
Arid and Semi-Arid Zones of Mexico: A Comprehensive Exploration of Biodiversity, Ecology, and Conservation
35